APA-viite

Smith, S. J., Pauly, G. T., Akram, A., Melody, K., Ambrose, Z., Schneider, J. P., & Hughes, S. H. (2016). Rilpivirine and Doravirine have complementary efficacies against NNRTI-Resistant HIV-1 mutants. J Acquir Immune Defic Syndr.

Chicago-tyylinen lähdeviittaus

Smith, Steven J., Gary T. Pauly, Aamir Akram, Kevin Melody, Zandrea Ambrose, Joel P. Schneider, ja Stephen H. Hughes. "Rilpivirine and Doravirine Have Complementary Efficacies against NNRTI-Resistant HIV-1 Mutants." J Acquir Immune Defic Syndr 2016.

MLA-viite

Smith, Steven J., et al. "Rilpivirine and Doravirine Have Complementary Efficacies against NNRTI-Resistant HIV-1 Mutants." J Acquir Immune Defic Syndr 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.